UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2025
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
Exhibit
Number
|
Description
|
99.1
|
02 July
2025 - Director/PDMR Shareholding
|
99.1
Haleon plc: Director/PDMR
Shareholding
2 July 2025: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces
notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by
Persons Discharging Managerial Responsibilities
("PDMRs").
On 30 June 2025, Dawn Allen, Chief Financial Officer, received the
vesting of awards of Haleon Ordinary Shares under the Haleon Share
Value Plan and Performance Share Plan.
The awards under the Share Value Plan and Performance Share Plan
were granted as part of her remuneration arrangements upon joining
Haleon, to compensate for forfeited incentives from her previous
employment.
The award under the Performance Share Plan includes dividends
accrued and was conditional on continued employment and based on
the satisfaction of the original performance conditions over the
performance period ending 31 March 2025 in respect of forfeited
incentives. This award (after tax on the gross award) must be
retained until the shareholding requirement is met, and in any
event for Executive Directors two years after receipt.
The awards are subject to malus and clawback
provisions.
The awards are subject to malus and clawback
provisions.
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
a)
|
Name
|
Dawn
Allen
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Chief
Financial Officer
|
b)
|
Initial notification /Amendment
|
Initial
Notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction
monitor
|
a)
|
Name
|
Haleon
plc
|
b)
|
LEI
|
549300PSB3WWEODCUP19
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
|
|
Identification
code
|
GB00BMX86B70
|
|
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares in respect of the vesting of the
Haleon plc Share Value Plan (Buyout award).
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
Nil
|
41,484
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
- Aggregated volume
|
N/A
|
|
|
- Price
|
|
|
|
e)
|
Date of the transaction
|
30 June 2025
|
f)
|
Place of the transaction
|
Outside a trading venue
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
|
|
Identification
code
|
GB00BMX86B70
|
|
|
b)
|
Nature of the transaction
|
Automatic disposal of Ordinary Shares resulting from Haleon plc
Share Value Plan (Buyout award) vesting to cover tax
liabilities.
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
£3.75638
|
19,565.960864
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
- Aggregated volume
|
N/A
|
|
|
- Price
|
|
|
|
e)
|
Date of the transaction
|
30 June 2025
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
|
|
Identification
code
|
GB00BMX86B70
|
|
|
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares in respect of the vesting of the
Haleon plc Performance Share Plan (Buyout).
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
Nil
|
136,528.6549
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
- Aggregated volume
|
N/A
|
|
|
- Price
|
|
|
|
e)
|
Date of the transaction
|
30 June 2025
|
f)
|
Place of the transaction
|
Outside a trading venue
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial instrument, type of
instrument
|
Ordinary Shares of £0.01 each
|
|
|
Identification
code
|
GB00BMX86B70
|
|
|
b)
|
Nature of the transaction
|
Automatic disposal of Ordinary Shares resulting from Haleon plc
Performance Share Plan (Buyout) vesting to cover tax
liabilities.
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
|
£3.75638
|
64,329.291
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
- Aggregated volume
|
N/A
|
|
|
- Price
|
|
|
|
e)
|
Date of the transaction
|
30 June 2025
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with
a purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans six major categories - Oral Health,
Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory
Health, Digestive Health and Therapeutic Skin Health and Other. Its
long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne,
Theraflu and Voltaren - are built on trusted science, innovation
and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
HALEON PLC
(Registrant)
|
Date:
July 2, 2025
|
By:
|
/s/
Amanda Mellor
|
|
|
Name:
|
Amanda
Mellor
|
|
|
Title:
|
Company
Secretary
|
|
|
|
|